Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Hualan ACYW135 Meningococcal Vaccine
NCT01661738Phase 2Completed
- Sponsor
- Hualan Biological Engineering Inc.
- Start
- May 2006
- Primary completion
- May 2006
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2, open-label, single-arm trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal meningitis, sponsored by Hualan Biological Engineering Inc. Primary endpoint: Safety (Systemic, Local, and Adverse Reactions) at Day 28. Started May 2006; status: completed.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT01661738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661738.